某种肠道细菌
菌群(微生物学)
明星(博弈论)
生物
动物
生态学
微生物学
细菌
物理
遗传学
天体物理学
作者
Chao Xue,Ganglei Li,Xinyu Gu,Yuanshuai Su,Qiuxian Zheng,Xin Yuan,Zhengyi Bao,Juan Lu,Lanjuan LI
出处
期刊:Research
[Universitas PGRI Madiun]
日期:2023-01-01
卷期号:6
被引量:1
标识
DOI:10.34133/research.0107
摘要
Akkermansia muciniphila ( A. muciniphila ) has drawn much attention as an important gut microbe strain in recent years. A. muciniphila can influence the occurrence and development of diseases of the endocrine, nervous, digestive, musculoskeletal, and respiratory systems and other diseases. It can also improve immunotherapy for some cancers. A. muciniphila is expected to become a new probiotic in addition to Lactobacillus and Bifidobacterium . An increase in A. muciniphila abundance through direct or indirect A. muciniphila supplementation may inhibit or even reverse disease progression. However, some contrary findings are found in type 2 diabetes mellitus and neurodegenerative diseases, where increased A. muciniphila abundance may aggravate the diseases. To enable a more comprehensive understanding of the role of A. muciniphila in diseases, we summarize the relevant information on A. muciniphila in different systemic diseases and introduce regulators of A. muciniphila abundance to promote the clinical transformation of A. muciniphila research.
科研通智能强力驱动
Strongly Powered by AbleSci AI